miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells

Warburg, 1956, On respiratory impairment in cancer cells, Science, 124, 269, 10.1126/science.124.3215.269 Meyer, 2008, Malignant gliomas in adults, New Engl. J. Med., 359, 1850, 10.1056/NEJMc086380 Wolf, 2011, Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme, J. Exp. Med., 208, 313, 10.1084/jem.20101470 Bao, 2006, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, 444, 756, 10.1038/nature05236 Beier, 2011, Chemoresistance of glioblastoma cancer stem cells-much more complex than expected, Mol. Cancer, 10, 128, 10.1186/1476-4598-10-128 Gilbertson, 2007, Making a tumour’s bed: glioblastoma stem cells and the vascular niche, Nat. Rev. Cancer, 7, 733, 10.1038/nrc2246 Morfouace, 2012, Comparison of spheroids formed by rat glioma stem cells and neural stem cells reveals differences in glucose metabolism and promising therapeutic applications, J. Biol. Chem., 287, 33664, 10.1074/jbc.M111.320028 Pistollato, 2010, Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma, Biochem. Pharmacol., 80, 1517, 10.1016/j.bcp.2010.08.003 Vlashi, 2011, Metabolic state of glioma stem cells and nontumorigenic cells, Proc. Natl. Acad. Sci. USA, 108, 16062, 10.1073/pnas.1106704108 Zhou, 2011, Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis, J. Biol. Chem., 286, 32843, 10.1074/jbc.M111.260935 Yi, 2012, Phosphofructokinase 1 glycosylation regulates cell growth and metabolism, Science, 337, 975, 10.1126/science.1222278 Michelakis, 2010, Metabolic modulation of glioblastoma with dichloroacetate, Sci. Transl. Med., 2, 31ra34, 10.1126/scitranslmed.3000677 Huang, 2010, Cancer stem cells in glioblastoma – molecular signaling and therapeutic targeting, Protein Cell, 1, 638, 10.1007/s13238-010-0078-y Persano, 2011, The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications, Sci. World J., 11, 1829, 10.1100/2011/736480 Covello, 2006, HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth, Genes Dev., 20, 557, 10.1101/gad.1399906 Ezashi, 2005, Low O2 tensions and the prevention of differentiation of hES cells, Proc. Natl. Acad. Sci. USA, 102, 4783, 10.1073/pnas.0501283102 Morrison, 2000, Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells, J. Neurosci., 20, 7370, 10.1523/JNEUROSCI.20-19-07370.2000 Li, 2009, Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells, Cancer Cell, 15, 501, 10.1016/j.ccr.2009.03.018 Heddleston, 2009, The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype, Cell Cycle, 8, 3274, 10.4161/cc.8.20.9701 Bar, 2010, Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres, Am. J. Pathol., 177, 1491, 10.2353/ajpath.2010.091021 Hermeking, 2012, MicroRNAs in the p53 network: micromanagement of tumour suppression, Nat. Rev. Cancer, 12, 613, 10.1038/nrc3318 Lujambio, 2012, The microcosmos of cancer, Nature, 482, 347, 10.1038/nature10888 Guessous, 2010, MicroRNA-34a is tumor suppressive in brain tumors and glioma stem cells, Cell Cycle, 9, 1031, 10.4161/cc.9.6.10987 Jeon, 2011, ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2, Cancer Res., 71, 3410, 10.1158/0008-5472.CAN-10-3340 Katsushima, 2012, Contribution of MICRORNA-1275 to claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells, J. Biol. Chem., 287, 27396, 10.1074/jbc.M112.359109 Schraivogel, 2011, CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells, EMBO J., 30, 4309, 10.1038/emboj.2011.301 Eichner, 2010, MiR-378(*) mediates metabolic shift in breast cancer cells via the PGC-1beta/ERRgamma transcriptional pathway, Cell Metab., 12, 352, 10.1016/j.cmet.2010.09.002 Kefas, 2010, Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells, Neuro Oncol., 12, 1102, 10.1093/neuonc/noq080 Jiang, 2012, A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells, EMBO J., 31, 1985, 10.1038/emboj.2012.45 Fang, 2012, MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene, J. Biol. Chem., 287, 23227, 10.1074/jbc.M112.373084 Peschiaroli, 2012, miR-143 regulates hexokinase 2 expression in cancer cells, Oncogene Gregersen, 2012, MicroRNA-143 down-regulates hexokinase 2 in colon cancer cells, BMC Cancer, 12, 232, 10.1186/1471-2407-12-232 Ernst, 2009, Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival, Clin. Cancer Res., 15, 6541, 10.1158/1078-0432.CCR-09-0695 Gilbert, 2010, Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence, Cancer Res., 70, 6870, 10.1158/0008-5472.CAN-10-1378 Dwarakanath, 2009, Clinical studies for improving radiotherapy with 2-deoxy-d-glucose: present status and future prospects, J. Cancer Res. Ther., 5, S21, 10.4103/0973-1482.55136 Singh, 2005, Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme, Strahlenther. Onkol., 181, 507, 10.1007/s00066-005-1320-z Wolf, 2010, Targeting metabolic remodeling in glioblastoma multiforme, Oncotarget, 1, 552, 10.18632/oncotarget.190 Clape, 2009, MiR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice, PLoS ONE, 4, e7542, 10.1371/journal.pone.0007542 Huang, 2012, MiR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells, Oncol. Rep., 28, 1831, 10.3892/or.2012.2015 Villadsen, 2012, The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer, Br. J. Cancer, 106, 366, 10.1038/bjc.2011.520 Xu, 2011, miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS, Mol. Cell. Biochem., 350, 207, 10.1007/s11010-010-0700-6 Koo, 2012, Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines, BMC Cancer, 12, 143, 10.1186/1471-2407-12-143 Zhang, 2006, Effect of 2-deoxy-d-glucose on various malignant cell lines in vitro, Anticancer Res., 26, 3561 El Mjiyad, 2011, Sugar-free approaches to cancer cell killing, Oncogene, 30, 253, 10.1038/onc.2010.466 Kern, 1987, Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-d-glucose, Surgery, 102, 380